Authors

• Peter Nash (ORCID: https://orcid.org/0000-0002-2571-788X)
• D. Willems (ORCID: https://orcid.org/0000-0001-8263-4047)
• Jason Eells
• V. Taieb (ORCID: https://orcid.org/0000-0003-0655-8630)
• Iain B. McInnes (ORCID: https://orcid.org/0000-0002-6462-4280)
• Philip J. Mease (ORCID: https://orcid.org/0000-0002-6620-0457)
• Richard Bruce Warren (ORCID: https://orcid.org/0000-0002-2918-6481)
• Nikos Lyris
• Jean‐Marie Grouin

Institutions

• Griffith University (AU)
• University of Washington (US)
• Manchester Academic Health Science Centre (GB)
• Swedish Medical Center (US)
• Swedish Medical Center (US)
• UCB Pharma (France) (FR)
• UCB Pharma (United Kingdom) (GB)
• NIHR Manchester Biomedical Research Centre (GB)
• Université de Rouen Normandie (FR)
• University of Glasgow (GB)
• UCB Pharma (Belgium) (BE)

Publication Details

Journal

Rheumatology and Therapy

Published

2024-08-09

DOI

https://doi.org/10.1007/s40744-024-00706-w

Citations

3

Primary Topic

Spondyloarthritis Studies and Treatments

Type

article

Field-Weighted Citation Impact

1.41

Funders

• National Institute for Health and Care Research
• Manchester Biomedical Research Centre
• UCB Pharma